Skip to main content

Nimodipine Dosage

Medically reviewed by Drugs.com. Last updated on Apr 19, 2024.

Applies to the following strengths: 30 mg; 60 mg/20 mL; 30 mg/10 mL; 30 mg/5 mL; 60 mg/10 mL

Usual Adult Dose for Subarachnoid Hemorrhage

60 mg orally, nasogastric, or gastric tube every 4 hours


Comments:

Use: Improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with SAH from ruptured intracranial berry aneurysms regardless of their post ictus neurological conditions (e.g., Hunt and Hess Grades I to V)

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Patients with cirrhosis: 30 mg orally every 4 hours

Comments:

Dose Adjustments

Concomitant use with strong CYP450 3A4 inducers/inhibitors: Avoid use.

Concomitant use with moderate/weak CYP450 3A4 inducers: Monitor for effectiveness; an increase in the dose of this drug may be considered.

Concomitant use with moderate/weak CYP450 3A4 inhibitors: Consider reducing the dose of this drug if hypotension occurs.

Precautions

US BOXED WARNINGS:
DEATH DUE TO INADVERTENT INTRAVENOUS ADMINISTRATION:


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

IV compatibility:

General:

Monitoring:

Patient advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.